Cardano for Global Health Supply

Use distributed network and to match diagnostics supply transactions, local distributors, and capital with Cardano tools to unlock access

Team delivered 14M diagnostics to 3 African countries through cloud tech, treasury, KYC/AML platform and digitized 3K trades $1.25B in value

Work with Atala Prism to pilot use of DID, VC, and Smart Contract combined with Kountable's existing platform and data to deliver PoC for governance, transparency, and capital to global health supply chains in African markets.  Kenya, Rwanda, Ethiopia, South Sudan, Ghana, South Africa currently supported by Kountable.

Kountable hosted Abbott executives and a room full of technologists and investors including Dor Garbash to kick off the execution of a program targeting 27M pregnant women across 21 countries in Africa.

We visited Kigali Rwanda to experience diagnostics in the field through oculus VR

Photos of the event can be seen here:

https://www.linkedin.com/feed/update/urn:li:activity:6867277070586773504

And a 2D version of the video and an overview of what we hope to scale can be seen here:

https://brand-studio.fortune.com/abbott/reimagining-health-care/?prx_t=EBUGAAAAAAofEQA

The impact will be substantial and the commercial implications of the collaboration can scale across the $60B global diagnostics market and improve health equity globally.

SDG goals:

Goal 3. Ensure healthy lives and promote well-being for all at all ages

SDG subgoals:

3.2 By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under‑5 mortality to at least as low as 25 per 1,000 live births

3.3 By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases

3.4 By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being

3.b Support the research and development of vaccines and medicines for the communicable and non‑communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all

3.d Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks

Key Performance Indicator (KPI):

3.2.1 Under‑5 mortality rate

3.2.2 Neonatal mortality rate

3.3.1 Number of new HIV infections per 1,000 uninfected population, by sex, age and key populations

3.3.2 Tuberculosis incidence per 100,000 population

3.3.3 Malaria incidence per 1,000 population

3.3.4 Hepatitis B incidence per 100,000 population

3.d.1 International Health Regulations (IHR) capacity and health emergency preparedness

#proposertoolsdg